Progesterone Supplementation in Threatened Abortion — Prothreat

Progesterone Resistance Clinical Trial

Official title:
Progesterone Supplementation in Threatened Abortion: Is it a Sound Practice?

Status Completed

Clinical Trial Summary

To decide whether progesterone supplementation in threatened abortion is a sound practice.

Clinical Trial Description

This study was conducted at Obstetrics and Gynecology Department, Tanta University in the period from January 2018 to December 2018. Patients: Eligible patients (n=190) were randomly allocated into 2 groups; study group who will receive progesterone supplementation (Prog.group) and control group who will receive no treatment (place.group). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03930212
Study type	Interventional
Source	Tanta University
Contact
Status	Completed
Phase	Phase 4
Start date	January 1, 2018
Completion date	December 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03356964` - Step Down FSH Approach and Late Follicular Phase in Progesterone Level	Early Phase 1
Completed	`NCT03519776` - Variation of Progesterone in IVF Cycles
Recruiting	`NCT06379113` - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients	Phase 2/Phase 3
Recruiting	`NCT06390904` - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients	Phase 2/Phase 3
Recruiting	`NCT05316935` - GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients	Phase 2/Phase 3
Completed	`NCT05062135` - Progesterone Action on Endometrium of PCOS	N/A